New Study Reveals How KRAS Cancer Cells Evade Treatment
How mRNA Decoding Errors Drive KRAS Resistance
Researchers at St. Jude Children's Research Hospital have identified a key mechanism behind treatment resistance in KRAS-driven cancers. The team focused on how errors in mRNA decoding during protein synthesis fuel tumor growth. This discovery points to new therapeutic targets for a stubborn class of cancers.
Health news
Vegan Diets May Reduce Gut Bacteria Diversity, Study Finds
Music with beats cuts stress hormone more than pink noise
Epigenetic Shifts Can Trigger Liver Cancer Without DNA Damage
Blood Clots and Brain Tumors Linked by Overactive PlateletsThe study examined the translation process, where cells read mRNA instructions to build proteins. Scientists found that a specific factor in this decoding step can be altered in KRAS-related tumors. This alteration allows cancer cells to survive standard therapies. Understanding this mechanism opens doors to drugs that block the resistance pathway.
Can Targeting Decoding Factors Reverse Resistance?
KRAS mutations are common in pancreatic, lung, and colorectal cancers. When the decoding machinery malfunctions, cells produce faulty proteins that help tumors adapt. The St. Jude team traced this to a specific protein involved in reading the genetic code. By targeting this factor, doctors may stop resistance before it takes hold.
Early lab results suggest that blocking the altered decoding factor reduces tumor growth in KRAS models. This approach could complement existing KRAS inhibitors. Clinical trials will be needed to confirm these findings in patients. The research highlights a previously overlooked angle in cancer biology.
What is KRAS and why does it matter? KRAS is a gene that controls cell growth. When mutated, it drives uncontrolled division in many cancers. Targeting it is a major focus of oncology research.
Frequently Asked Questions
How does mRNA decoding relate to treatment resistance? Errors in decoding let cancer cells build proteins that help them survive drugs. Fixing or blocking this process may restore drug sensitivity.
Where can I read the full study? The findings were published in a peer-reviewed journal. Search for St. Jude KRAS mRNA decoding resistanceto locate the paper.